BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15120223)

  • 1. Lower dose intraventricular T-PA fibrinolysis: case report.
    Deutsch H; Rodriguez JC; Titton RL
    Surg Neurol; 2004 May; 61(5):460-3; discussion 463. PubMed ID: 15120223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
    Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
    Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.
    Findlay JM; Jacka MJ
    Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy after intraventricular haemorrhage].
    Gadegaard KH; Dahl BL; Hansen TS
    Ugeskr Laeger; 2010 May; 172(19):1440-1. PubMed ID: 20470653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations: no absolute contraindications as rescue therapy prior to surgical repair or embolization?
    Jorens PG; Menovsky TM; Voormolen MH; Van Den Brande E; Parizel PM
    Clin Neurol Neurosurg; 2009 Jul; 111(6):544-50. PubMed ID: 19328624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage.
    Fountas KN; Kapsalaki EZ; Parish DC; Smith B; Smisson HF; Johnston KW; Robinson JS
    South Med J; 2005 Aug; 98(8):767-73. PubMed ID: 16144170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal arterial occlusion with LIF using rTPA.
    Hayreh SS
    Ophthalmology; 1999 Jul; 106(7):1236-9. PubMed ID: 10406599
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage.
    Volbers B; Wagner I; Willfarth W; Doerfler A; Schwab S; Staykov D
    Stroke; 2013 Feb; 44(2):362-6. PubMed ID: 23306318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing early results and complication rates of the thrombolytic treatment of lower limb ischemia with recombinant tissue-type plasminogen activator.
    Asciutto G; Geier B; Marpe B; Hummel T; Mumme A
    Chir Ital; 2006; 58(5):597-604. PubMed ID: 17069188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of intraventricular hematoma with tissue plasminogen activator. Case report.
    Findlay JM; Weir BK; Stollery DE
    J Neurosurg; 1991 May; 74(5):803-7. PubMed ID: 1901601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.
    Hall B; Parker D; Carhuapoma JR
    Neurocrit Care; 2005; 3(2):153-6. PubMed ID: 16174886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
    Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
    Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular tissue plasminogen activator for intraventricular hemorrhage caused by an arteriovenous malformation.
    Keefe K; Kebriaei M; Gard A; Patil AA
    J Clin Neurosci; 2014 Mar; 21(3):526-9. PubMed ID: 24134809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations.
    Mayfrank L; Rohde V; Gilsbach JM
    Br J Neurosurg; 1999 Apr; 13(2):128-31. PubMed ID: 10616579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.
    Mayfrank L; Lippitz B; Groth M; Bertalanffy H; Gilsbach JM
    Acta Neurochir (Wien); 1993; 122(1-2):32-8. PubMed ID: 8333306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Combined External Ventricular Drainage with Intraventricular Fibrinolysis for the Treatment of Intraventricular Haemorrhage with Acute Obstructive Hydrocephalus.
    Luong CQ; Nguyen AD; Nguyen CV; Mai TD; Nguyen TA; Do SN; Dao PV; Pham HTM; Pham DT; Ngo HM; Nguyen QH; Nguyen DT; Tran TH; Le KV; Do NT; Ngo ND; Nguyen VD; Ngo HD; Hoang HB; Vu HV; Vu LT; Ngo BT; Nguyen BX; Khuong DQ; Nguyen DT; Vuong TX; Be TH; Gaberel T; Nguyen LV
    Cerebrovasc Dis Extra; 2019; 9(2):77-89. PubMed ID: 31408859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data.
    Seifert V
    Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
    Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.